Advertisement
Canada markets open in 8 hours 35 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7318
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    83.45
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    91,539.18
    +911.44 (+1.01%)
     
  • CMC Crypto 200

    1,436.71
    +21.95 (+1.55%)
     
  • GOLD FUTURES

    2,340.80
    -1.30 (-0.06%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,729.50
    +122.75 (+0.70%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,380.93
    +828.77 (+2.21%)
     
  • CAD/EUR

    0.6833
    -0.0003 (-0.04%)
     

Top Ranked Momentum Stocks to Buy for January 13th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 13th:

Karyopharm Therapeutics Inc. (KPTI): This oncology-focused pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Karyopharm Therapeutics Inc. Price and Consensus

Karyopharm Therapeutics Inc. Price and Consensus
Karyopharm Therapeutics Inc. Price and Consensus

Karyopharm Therapeutics Inc. price-consensus-chart | Karyopharm Therapeutics Inc. Quote

Karyopharm Therapeutics’ shares gained 9.7% over the last one month more than S&P 500’s gain of 3.1%. The company possesses a Momentum Score of A.

Karyopharm Therapeutics Inc. Price

Karyopharm Therapeutics Inc. Price
Karyopharm Therapeutics Inc. Price

Karyopharm Therapeutics Inc. price | Karyopharm Therapeutics Inc. Quote

ADVERTISEMENT

PLDT Inc. (PHI): This telecommunications company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

PLDT Inc. Price and Consensus

PLDT Inc. Price and Consensus
PLDT Inc. Price and Consensus

PLDT Inc. price-consensus-chart | PLDT Inc. Quote

PLDT’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.

PLDT Inc. Price

PLDT Inc. Price
PLDT Inc. Price

PLDT Inc. price | PLDT Inc. Quote

Exact Sciences Corporation (EXAS): This molecular diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.

Exact Sciences Corporation Price and Consensus

Exact Sciences Corporation Price and Consensus
Exact Sciences Corporation Price and Consensus

Exact Sciences Corporation price-consensus-chart | Exact Sciences Corporation Quote

Exact Sciences’ shares gained 19.8% over the last one month. The company possesses a Momentum Score of A.

Exact Sciences Corporation Price

Exact Sciences Corporation Price
Exact Sciences Corporation Price

Exact Sciences Corporation price | Exact Sciences Corporation Quote

AquaVenture Holdings Limited (WAAS): This water-as-a-service solutions provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

AquaVenture Holdings Ltd. Price and Consensus

AquaVenture Holdings Ltd. Price and Consensus
AquaVenture Holdings Ltd. Price and Consensus

AquaVenture Holdings Ltd. price-consensus-chart | AquaVenture Holdings Ltd. Quote

AquaVenture’s shares gained 26.7% over the last one month. The company possesses a Momentum Score of B.

AquaVenture Holdings Ltd. Price

AquaVenture Holdings Ltd. Price
AquaVenture Holdings Ltd. Price

AquaVenture Holdings Ltd. price | AquaVenture Holdings Ltd. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AquaVenture Holdings Ltd. (WAAS) : Free Stock Analysis Report
 
PLDT Inc. (PHI) : Free Stock Analysis Report
 
Karyopharm Therapeutics Inc. (KPTI) : Free Stock Analysis Report
 
Exact Sciences Corporation (EXAS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research